PepGen Inc.
For the period ended Dec 31, 2025. Filed Mar 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 4, 2026
PEPG$4.61+92.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(IN THOUSANDS, EXCEPT SHARE AMOUNTS)
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | AdditionalPaid-inCapital | AccumulatedOtherComprehensiveIncome (Loss) | AccumulatedDeficit | TotalStockholders’Equity | |
| Balance as of December 31, 2023 | 23,823,241 | $2 | $289,867 | $34 | $(181,482) | $108,421 |
| Issuance of stock in public offering, net of underwriters' fees and issuance costs | 7,530,000 | 1 | 76,351 | — | — | 76,352 |
| Issuance of common stock from At-the-Market Sales Agreement, net of underwriters' fees | 1,000,000 | — | 9,900 | — | — | 9,900 |
| Issuance of stock under the employee stock purchase plan | 56,540 | — | 252 | — | — | 252 |
| Exercise of stock options | 209,882 | — | 2,230 | — | — | 2,230 |
| Stock-based compensation expense | — | — | 11,457 | — | — | 11,457 |
| Unrealized gain on marketable securities | — | — | — | 39 | — | 39 |
| Cumulative translation adjustment arising during the period | — | — | — | (50) | — | (50) |
| Net loss | — | — | — | — | (89,981) | (89,981) |
| Balance as of December 31, 2024 | 32,619,663 | $3 | $390,057 | $23 | $(271,463) | $118,620 |
| Issuance of stock in public offering, net of underwriters' fees and issuance costs | 35,937,500 | 4 | 107,575 | — | — | 107,579 |
| Vesting of restricted stock and performance stock units | 101,280 | — | — | — | — | — |
| Issuance of stock under the employee stock purchase plan | 191,615 | — | 236 | — | — | 236 |
| Exercise of stock options | 24,886 | — | 67 | — | — | 67 |
| Stock-based compensation expense | — | — | 10,609 | — | — | 10,609 |
| Unrealized loss on marketable securities | — | — | — | (12) | — | (12) |
| Net loss | — | — | — | — | (89,655) | (89,655) |
| Balance as of December 31, 2025 | 68,874,944 | $7 | $508,544 | $11 | $(361,118) | $147,444 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.